Education
About Us
Working with TipRanks
Follow Us
ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ:BIB
BIB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$47.20 - $69.56
Previous Close$51.11
Volume3.68K
Average Volume (3M)10.88K
Market Cap
$62.14M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.88
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Mar 26, 2025Dividend Yield2.01%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume8,438
30 Day Avg. Volume10,878
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.18% Other Institutional Investors
98.82% Public Companies and
Individual Investors
BIB FAQ
What was ProShares Ultra Nasdaq Biotechnology’s price range in the past 12 months?
ProShares Ultra Nasdaq Biotechnology lowest stock price was $47.20 and its highest was $69.56 in the past 12 months.
What is ProShares Ultra Nasdaq Biotechnology’s market cap?
ProShares Ultra Nasdaq Biotechnology’s market cap is $62.14M.
When is ProShares Ultra Nasdaq Biotechnology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ProShares Ultra Nasdaq Biotechnology’s earnings last quarter?
Currently, no data Available
Is ProShares Ultra Nasdaq Biotechnology overvalued?
According to Wall Street analysts ProShares Ultra Nasdaq Biotechnology’s price is currently Overvalued.
Does ProShares Ultra Nasdaq Biotechnology pay dividends?
ProShares Ultra Nasdaq Biotechnology pays a Quarterly dividend of $0.13 which represents an annual dividend yield of 2.01%. See more information on ProShares Ultra Nasdaq Biotechnology dividends here
What is ProShares Ultra Nasdaq Biotechnology’s EPS estimate?
ProShares Ultra Nasdaq Biotechnology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProShares Ultra Nasdaq Biotechnology have?
Currently, no data Available
What happened to ProShares Ultra Nasdaq Biotechnology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ProShares Ultra Nasdaq Biotechnology?
Currently, no hedge funds are holding shares in BIB